IP Library Granted Patent US 10,196,596
Granted Patent B2
US 10,196,596 · App. 15/050,356 · Granted Feb 5, 2019

Engineered lumenized vascular networks and support matrix

Inventors: James A. Glazier (Bloomington, IN); Abdelkrim Alileche (Boise, ID); Abbas Shirinifard (Bloomington, IN); Dragos Amarie (Bloomington, IN)
Assignee: National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR)
C12M21/08A61K35/44C12M23/10C12M23/20C12N5/0068C12N2533/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,196,596
App. No.
15/050,356
Granted
Feb 5, 2019
Kind
B2
Abstract

Disclosed herein are capillary fabrication devices comprising living cells within a support medium. Culture of the cells produces viable lumenized capillary networks with natural or pre-determined geometries and ECM and basement membrane associated with the capillary networks. The capillary networks and the ECM and basement membrane detachable from the capillary networks are useful for tissue engineering applications.

Claims (20)

1. A device for fabrication of engineered capillary networks comprising:

endothelial lineage cells;

a non-treated polystyrene cell-culture surface; and

a low-density support-generating medium, the low-density support-generating medium comprising a gel forming material and a liquid cell-culture medium in a ratio of 1:30 to 1:60, wherein the gel forming material is substantially dissolved in the cell-culture medium and forms a support medium having a thickness of between 20 microns and 100 microns, and wherein the support medium covers the endothelial lineage cells and the cell-culture medium.

2. The device of claim 1 , wherein the endothelial lineage cells are selected from the group consisting of stem cells, endothelial progenitor cells, circulating endothelial cells, and lymphatic endothelial cells.

3. The device of claim 1 , further comprising at least one additional cell type selected from the group consisting of pericytes, smooth muscle cells, fibroblasts, and any combination thereof.

4. The device of claim 1 , wherein the non-treated polystyrene cell-culture surface comprises at least one hydrophobic region.

5. The device of claim 1 , wherein the non-treated polystyrene cell-culture surface comprises a coating of at least one temperature sensitive polymer.

6. The device of claim 1 , wherein the non-treated polystyrene cell-culture surface is modified by etching, stamping, contact printing, UV laser ablation, or any combination thereof.

7. The device of claim 1 , wherein the liquid cell-culture medium comprises one or more components selected from the group consisting of serum albumin, a bicarbonate-base, a HEPES buffer, and an extracellular matrix (ECM) protein.

8. The device of claim 1 , wherein the gel forming material comprises at least one protein selected from the group consisting of laminin, collagen IV, heparan sulfate proteoglycans, entactin/nidogen, TGF-β, epidermal growth factor, insulin-like growth factor, fibroblast growth factor, and tissue plasminogen activator.

9. The device of claim 1 , wherein the gel-forming material is dissolved in the liquid cell-culture medium to yield an ECM protein concentration of from 170 μg ECM proteins per ml of liquid cell-culture medium to 350 μg ECM proteins per ml of liquid cell-culture medium.

10. The device of claim 1 , wherein the support medium harbors the endothelial lineage cells.

11. The device of claim 1 , wherein the support medium having a thickness of between 20 microns and 100 microns on the non-treated polystyrene cell-culture surface.

12. The device of claim 1 , wherein the support medium has a thickness from 20 microns to 40 microns on the non-treated polystyrene cell-culture surface.

13. The device of claim 1 , wherein the non-treated polystyrene cell-culture surface comprises a network-like pattern containing regions of varying hydrophobicity.

14. The device of claim 1 , wherein the gel forming material is MATRIGEL.

15. The device of claim 1 , wherein the gel forming material and the liquid cell-culture medium are in a ratio of 1:30 to 1:60, and gel forming material is MATRIGEL.

16. The device of claim 1 , wherein the gel forming material and the liquid cell-culture medium are in a ratio of 1:30 to 1:60, the support medium has a thickness from 20 microns to 40 microns on the non-treated polystyrene cell-culture surface, and gel forming material is MATRIGEL.

17. The device of claim 1 , wherein the gel forming material and the liquid cell-culture medium are in a ratio of 1:30 to 1:60, the support medium has a thickness from 20 microns to 40 microns on the non-treated polystyrene cell-culture surface, the non-treated polystyrene cell-culture surface comprises a network-like pattern containing regions of varying hydrophobicity, and gel forming material is MATRIGEL.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2019
From: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
To: THE TRUSTEES OF INDIANA UNIVERSITY
Reel/Frame 048117/0493 →
Continuity (3)
Division 13635043
Provisional Application 61313886 · Mar 15, 2010
Related Publication 20160168523A1 · Jun 16, 2016
Cited By (2)
US 12,427,229 US 12,678,067